4000-520-616
欢迎来到免疫在线!(蚂蚁淘生物旗下平台)  请登录 |  免费注册 |  询价篮
主营:原厂直采,平行进口,授权代理(蚂蚁淘为您服务)
咨询热线电话
4000-520-616
当前位置: 首页 > 产品中心 > Protein_purification_kit > Acrobosystems/Human 4-1BB/TNFRSF9蛋白,His标签,低内毒素/1mg(500ug×2)/41B
商品详细Acrobosystems/Human 4-1BB/TNFRSF9蛋白,His标签,低内毒素/1mg(500ug×2)/41B
Acrobosystems/Human 4-1BB/TNFRSF9蛋白,His标签,低内毒素/1mg(500ug×2)/41B
Acrobosystems/Human 4-1BB/TNFRSF9蛋白,His标签,低内毒素/1mg(500ug×2)/41B
商品编号: 41B
品牌: ACROBiosystems
市场价: ¥39000.00
美元价: 19500.00
产地: 美国(厂家直采)
公司:
产品分类: 蛋白纯化试剂盒
公司分类: Protein_purification_kit
联系Q Q: 3392242852
电话号码: 4000-520-616
电子邮箱: info@ebiomall.com
商品介绍
  • Synonym
    TNFRSF9,4-1BB,CD137,CDw137,ILA
  • Source
    Human 4-1BB, His Tag, low endotoxin (41B-H522a) is expressed from human 293 cells (HEK293). It contains AA Leu 24 - Gln 186 (Accession # Q07011-1).
    Predicted N-terminus: Leu 24
    Request for sequence
  • Molecular Characterization
    Online(Leu 24 - Gln 186) Q07011-1

    This protein carries a polyhistidine tag at the C-terminus.

    The protein has a calculated MW of 19.2 kDa. The protein migrates as 28-35 kDa under reducing (R) condition (SDS-PAGE) due to glycosylation.

  • Endotoxin
    Less than 0.01 EU per μg by the LAL method.
  • Purity

    >90% as determined by SDS-PAGE.

  • Formulation

    Lyophilized from 0.22 μm filtered solution in PBS, pH7.4. Normally trehalose is added as protectant before lyophilization.

    Contact us for customized product form or formulation.

  • Reconstitution

    Please see Certificate of Analysis for specific instructions.

    For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.

  • Storage

    For long term storage, the product should be stored at lyophilized state at -20°C or lower.

    Please avoid repeated freeze-thaw cycles.

    This product is stable after storage at:

    1. -20°C to -70°C for 12 months in lyophilized state;
    2. -70°C for 3 months under sterile conditions after reconstitution.
SDS-PAGE
Human 4-1BB, His Tag, low endotoxin (Cat. No. 41B-H522a) SDS-PAGE gel

Human 4-1BB, His Tag, low endotoxin on SDS-PAGE under reducing (R) condition. The gel was stained overnight with Coomassie Blue. The purity of the protein is greater than 90%.

Bioactivity-ELISA
Human 4-1BB, His Tag, low endotoxinHuman 4-1BB, His Tag, low endotoxin (Cat. No. 41B-H522a) ELISA bioactivity

Immobilized Human 4-1BB Ligand (71-254), Fc Tag, active trimer (Cat. No. 41L-H5265) at 1 μg/mL (100 μL/well) can bind Human 4-1BB, His Tag, low endotoxin (Cat. No. 41B-H522a) with a linear range of 0.2-3 ng/mL (QC tested).

Protocol
Human 4-1BB, His Tag, low endotoxinHuman 4-1BB, His Tag, low endotoxin (Cat. No. 41B-H522a) ELISA bioactivity

Immobilized Human 4-1BB, His Tag, low endotoxin (Cat. No. 41B-H522a) at 1 μg/mL (100 μL/well) can bind Anti-Human 4-1BBMAb, Human IgG4 with a linear range of 0.1-3 ng/mL (Routinely tested).

Protocol
Bioactivity-BLI
Human_FcRn_Heterodimer_Protein_Bli

Loaded Human 4-1BB Ligand (71-254), Fc Tag, active trimer (Cat. No. 41L-H5265) on Protein A Biosensor, can bind Human 4‑1BB, His Tag, low endotoxin (Cat. No. 41B-H522a) with an affinity constant of 10.6 nM as determined in BLI assay (ForteBio Octet Red96e) (Routinely tested).

Protocol
  • Background
    4-1BB is also known as CD137, tumor necrosis factor receptor superfamily member 9 (TNFRSF9), induced by lymphocyte activation (ILA), is a co-stimulatory molecule of the tumor necrosis factor (TNF) receptor superfamily. CD137 can be expressed by activated T cells, but to a larger extent on CD8 than on CD4 T cells. In addition, CD137 expression is found on dendritic cells, follicular dendritic cells, natural killer cells, granulocytes and cells of blood vessel walls at sites of inflammation. The best characterized activity of CD137 is its costimulatory activity for activated T cells. Crosslinking of CD137 enhances T cell proliferation, IL-2 secretion survival and cytolytic activity. Further, it can enhance immune activity to eliminate tumors in mice. CD137 can enhance activation-induced T cell apoptosis when triggered by engagement of the TCR/CD3 complex. In addition, 4-1BB/4-1BBL co-stimulatory pathway has been shown to augment secondary CTL responses to several viruses, and meanwhile augment anti-tumor immunity. 4-1BB thus is a promising candidate for immunotherapy of human cancer. CD137 has been shown to interact with TRAF2.
  • References
  • Please contact us via TechSupport@acrobiosystems.com if you have any question on this product.

品牌介绍
ACROBiosystems 是一个具有全球范围影响力的生物技术领导品牌,其运营包括了位于北美、 欧洲和亚洲的数家公司, 主要为生命科学研究、生物制药与疫病诊断等行业提供产品、技术服务和临床应用等解决方案,同时致力于在蛋白组学、药物发现和细胞治疗等领域推广面向工业化和临床转化的技术和产品。ACROBiosystems 的业务遍及全球50多个国家和地区,并通过在北美、亚洲、欧洲等世界范围的不同时区设立分支机构以服务于当地客户与经销商。